Anavex Life Sciences
AVXL
AVXL
138 hedge funds and large institutions have $249M invested in Anavex Life Sciences in 2022 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 61 increasing their positions, 28 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
25% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 24
39% less call options, than puts
Call options by funds: $17.1M | Put options by funds: $28M
Holders
138
Holding in Top 10
–
Calls
$17.1M
Puts
$28M
Top Buyers
| 1 | +$13.4M | |
| 2 | +$5.83M | |
| 3 | +$3.64M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.47M |
| 5 |
BlackRock
New York
|
+$2.44M |
Top Sellers
| 1 | -$3.79M | |
| 2 | -$2.55M | |
| 3 | -$2.39M | |
| 4 |
Barclays
London,
United Kingdom
|
-$1.67M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$1M |